$SNPS

DE GEUS AART sold $11.1M of SNPS

DE GEUS AART (EXECUTIVE CHAIR) sold 25,000 shares of SYNOPSYS INC (SNPS) at $445.55 ($11.14M total) on 2026-08-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DE GEUS AART
Published Aug 31, 2026, 10:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 11:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNPS
Neutral
medium confidence
Mentioned
$SNPS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

The disclosed sale provides fresh data for traders monitoring insider sentiment.

02

Market read

New insider sale information, modest size, limited immediate market impact.

03

What to watch

Potential tax planning or diversification motives behind the 10b5‑1 execution.

Relevance 6/10Novelty 6/10Timing: filing posted 2026‑08‑31 after market close

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan indicates pre‑arranged sales.

Company-level read

Ticker impact

$SNPSNeutralMedium confidence
Context

Executive Chair Aart de Geus sold 25,000 shares for $11.1M via a 10b5‑1 plan, reducing his stake to 120,421 shares.

Expected impact

Potential short‑term downward pressure, likely limited to a few basis points.

Evidence & confidence

The sale is a primary Form 4 filing, new information, but $11M is not material for a large‑cap like Synopsys.

Market effects

Minimal impact on EDA/software sector; insider activity is routine.

U.S. market only; no broader regional effect.

Low; Synopsys is a global player but the transaction is company‑specific.

Counterpoint

The sale could be a routine liquidity event, not a negative signal.

Key entities

  • Synopsys Inc.

    U.S. listed EDA software provider (ticker SNPS).

  • Aart de Geus

    Executive Chair of Synopsys, insider selling shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SNPSMedAI 8/10

Should $1b Amazon Deal Require Action From Synopsys (SNPS) Investors?

Synopsys (SNPS) announced a multiyear, $1B+ deal with Amazon to expand the use of its EDA, IP, and AI-based engineering tools for custom silicon. The agreement aligns with Synopsys' AI-centric roadmap and long-term financial goals. Analysts highlight potential demand visibility and capital allocation influences, while noting risks like Ansys integration and litigation. Current earnings are $1.1B, with forecasts for $2.6B by 2029, implying 13% yearly revenue growth.

$SNPSHigh

Synopsys (SNPS) Announces $1 Billion Accelerated Share Repurchas

Synopsys (SNPS) announced a $1 billion accelerated share repurchase agreement with JPMorgan Chase, aiming to buy back 1.7 million shares initially. The company's shares rose over 1% in pre-market trading. According to GuruFocus, SNPS is modestly undervalued by 24%, with a GF Value of $659.43. The company has a GF Score of 95/100, indicating strong financial health and growth potential. However, insider activity shows no purchases and $48.2 million in sales over the past year.